Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 7, 2010 - Issue 12
Submit an article Journal homepage
723
Views
70
CrossRef citations to date
0
Altmetric
Reviews

Development of cytarabine prodrugs and delivery systems for leukemia treatment

Bhupender S Chhikara University of Rhode Island, College of Pharmacy, Department of Biomedical and Pharmaceutical Sciences, 41 Lower College Road, Kingston, RI 02881, USA +1 401 874 4471; +1 401 874 5787; [email protected]
&
Keykavous Parang
Pages 1399-1414 | Published online: 22 Oct 2010

Citations (70)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jian-Wei Chen, Qi-Hao Wu, David C. Rowley, Ammar M.Q. Al-Kareef & Hong Wang. (2015) Anticancer agent-based marine natural products and related compounds. Journal of Asian Natural Products Research 17:2, pages 199-216.
Read now
Sebastian Brennig, Ina Rattmann, Nico Lachmann, Axel Schambach, David A. Williams & Thomas Moritz. (2012) In vivo enrichment of cytidine deaminase gene-modified hematopoietic cells by prolonged cytosine-arabinoside application. Cytotherapy 14:4, pages 451-460.
Read now

Articles from other publishers (68)

P. Facey. 2024. Pharmacognosy. Pharmacognosy 411 439 .
Nasrullah Jan, Hassan Shah, Safiullah Khan, Faiza Nasar, Asadullah Madni, Syed Faisal Badshah, Ahsan Ali & Mohammad F. Bostanudin. (2023) Old drug, new tricks: polymer-based nanoscale systems for effective cytarabine delivery. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Yue-Ming Yu, Fan-Zhi Bu, Su-Su Meng, Cui-Wei Yan, Zhi-Yong Wu & Yan-Tuan Li. (2023) The first nano-cocrystal formulation of marine drug cytarabine with uracil based on cocrystal nanonization strategy for long-acting injection exhibiting enhanced antitumor activity. International Journal of Pharmaceutics 644, pages 123300.
Crossref
Nasrullah Jan, Asadullah Madni, Hassan Shah, Safiullah Khan, Qazi Amir Ijaz, Syed Faisal Badshah, Ahsan Ali, Umair Khurshid & Mohammad F. Bostanudin. (2023) Development and Statistical Optimization of Polymer-Based Nanoparticulate Delivery System for Enhancing Cytarabine Efficacy in Leukemia Treatment. Journal of Pharmaceutical Innovation.
Crossref
M. T. Rodgers, Yakubu S. Seidu & E. Israel. (2023) Influence of 2′-Modifications (O-Methylation, Fluorination, and Stereochemical Inversion) on the Base Pairing Energies of Protonated Cytidine Nucleoside Analogue Base Pairs: Implications for the Stabilities of i -Motif Structures . Journal of the American Society for Mass Spectrometry 34:7, pages 1400-1416.
Crossref
Martin Balouch, Kateřina Storchmannová, František Štěpánek & Karel Berka. (2023) Computational Prodrug Design Methodology for Liposome Formulability Enhancement of Small-Molecule APIs. Molecular Pharmaceutics 20:4, pages 2119-2127.
Crossref
Yuanchao Jia, Yuxin Jiang, Yonglong He, Wanting Zhang, Jiahui Zou, Kosheli Thapa Magar, Hamza Boucetta, Chao Teng & Wei He. (2023) Approved Nanomedicine against Diseases. Pharmaceutics 15:3, pages 774.
Crossref
Surya K. De. 2023. Medicines for Cancer. Medicines for Cancer 7 159 .
Anshul SharmaKeshav DhimanAnshul SharmaKamya GoyalVinay PanditM. S. AshawatShammy Jindal. (2022) Application of Nanocarrier in Drug development with special Emphasis on Liposomes: A Review. Asian Journal of Pharmacy and Technology, pages 320-328.
Crossref
Junyi Ren, Bo Wang, Qifeng Wu & Guiling Wang. (2022) Combination of niclosamide and current therapies to overcome resistance for cancer: New frontiers for an old drug. Biomedicine & Pharmacotherapy 155, pages 113789.
Crossref
Yonglong He, Wanting Zhang, Qingqing Xiao, Lifang Fan, Dechun Huang, Wei Chen & Wei He. (2022) Liposomes and liposome-like nanoparticles: From anti-fungal infection to the COVID-19 pandemic treatment. Asian Journal of Pharmaceutical Sciences 17:6, pages 817-837.
Crossref
Chitrangda Singh, Chandan Bhogendra Jha, Navneet Kumar, Ragini Singh, Himanshu Ojha, Sreedevi Upadhyayula, Raunak Varshney & Rashi Mathur. (2022) An integrated experimental and simulation study on the loading of cytarabine in a biocompatible zinc imidazole metal–organic framework. Journal of Materials Science 57:39, pages 18561-18577.
Crossref
Giuseppina Ioele, Martina Chieffallo, Maria Antonietta Occhiuzzi, Michele De Luca, Antonio Garofalo, Gaetano Ragno & Fedora Grande. (2022) Anticancer Drugs: Recent Strategies to Improve Stability Profile, Pharmacokinetic and Pharmacodynamic Properties. Molecules 27:17, pages 5436.
Crossref
Saeed Noorolyai, Elham Baghbani, Shima Rahmani, Mahdi Abdoli Shadbad, Nooshin Montazami, Farinaz Jigari-Asl, Aysan Fallah Vazirabad & Behzad Baradaran. (2022) hsa-miR-34a-5p potentiates cytarabine-mediated cell cycle arrest in MDA-MB-231 cells: a novel combination therapy. Pathology - Research and Practice 236, pages 154004.
Crossref
Shayan Maryam, Kashif Barkat, Ikrima Khalid, Yasir Mehmood, Muhammad Ali Syed, Nadia Shamshad Malik & Maryam Aslam. (2021) Polymeric blends of okra gum/gelatin prepared by aqueous polymerization technique: their characterization and toxicological evaluation. Polymer Bulletin 79:7, pages 5339-5363.
Crossref
Soon Yong Park, Hyeongrok Choi & Jin Woong Chung. (2022) Reptiles as Promising Sources of Medicinal Natural Products for Cancer Therapeutic Drugs. Pharmaceutics 14:4, pages 874.
Crossref
Victor Pallarès, Ugutz Unzueta, Aïda Falgàs, Anna Aviñó, Yáiza Núñez, Annabel García-León, Laura Sánchez-García, Naroa Serna, Alberto Gallardo, Lorena Alba-Castellón, Patricia Álamo, Jorge Sierra, Lídia Cedó, Ramon Eritja, Antonio Villaverde, Esther Vázquez, Isolda Casanova & Ramon Mangues. (2022) A multivalent Ara-C-prodrug nanoconjugate achieves selective ablation of leukemic cells in an acute myeloid leukemia mouse model. Biomaterials 280, pages 121258.
Crossref
Saghar Mozaffari, David Salehi, Parvin Mahdipoor, Richard Beuttler, Rakesh Tiwari, Hamidreza Montazeri Aliabadi & Keykavous Parang. (2021) Design and application of hybrid cyclic-linear peptide-doxorubicin conjugates as a strategy to overcome doxorubicin resistance and toxicity. European Journal of Medicinal Chemistry 226, pages 113836.
Crossref
Pratheppa Rajagopal, Giridhara R. Jayandharan & Uma Maheswari Krishnan. (2021) Evaluation of the Anticancer Activity of pH-Sensitive Polyketal Nanoparticles for Acute Myeloid Leukemia. Molecular Pharmaceutics 18:5, pages 2015-2031.
Crossref
Ai-Mei Liao, Ying Zhang, Yinchen Hou, Ji-Hong Huang, Ming Hui, Kyung-Ku Lee, Kwang Youl Lee & ChangJu Chun. (2021) Preparation, characterization, and cytotoxicity evaluation of self-assembled nanoparticles of diosgenin-cytarabine conjugate. Food and Chemical Toxicology 151, pages 112101.
Crossref
Jing Liu, Xiang Li, Lina Liu, Qiang Bai, Ning Sui & Zhiling Zhu. (2021) Self-assembled ultrasmall silver nanoclusters on liposome for topical antimicrobial delivery. Colloids and Surfaces B: Biointerfaces 200, pages 111618.
Crossref
Katherine L. Seley-Radtke, Joy E. Thames & Charles D. WatersIIIIII. 2021. Coronaviruses and other Novel Antiviral Targets. Coronaviruses and other Novel Antiviral Targets 109 132 .
Nicholas J. Collier & Lesley E. Rhodes. (2020) Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities. Molecules 25:22, pages 5398.
Crossref
Sergio O. Angel, Laura Vanagas, Diego M. Ruiz, Constanza Cristaldi, Ana M. Saldarriaga Cartagena & William J. SullivanJr.Jr.. (2020) Emerging Therapeutic Targets Against Toxoplasma gondii: Update on DNA Repair Response Inhibitors and Genotoxic Drugs. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Bhupender S. Chhikara, Sajda Ashraf, Saghar Mozaffari, Nicole St. Jeans, Dindyal Mandal, Rakesh Kumar Tiwari, Zaheer Ul-Haq & Keykavous Parang. (2020) Phenylpyrazalopyrimidines as Tyrosine Kinase Inhibitors: Synthesis, Antiproliferative Activity, and Molecular Simulations. Molecules 25:9, pages 2135.
Crossref
Bahare Salehi, Zeliha Selamoglu, Ksenija S. Mileski, Raffaele Pezzani, Marco Redaelli, William C. Cho, Farzad Kobarfard, Sadegh Rajabi, Miquel Martorell, Pradeep Kumar, Natália Martins, Tuhin Subhra Santra & Javad Sharifi-Rad. (2019) Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine. Biomolecules 9:12, pages 773.
Crossref
Aida Vitkevičienė, Vytautas Janulis, Andrius Žučenka, Veronika Borutinskaitė, Algirdas Kaupinis, Mindaugas Valius, Laimonas Griškevičius & Rūta Navakauskienė. (2019) Oxidative phosphorylation inhibition induces anticancerous changes in therapy‐resistant–acute myeloid leukemia patient cells. Molecular Carcinogenesis 58:11, pages 2008-2016.
Crossref
Diana H. Quan, Gayathri Nagalingam, Ian Luck, Nicholas Proschogo, Vijaykumar Pillalamarri, Anthony Addlagatta, Elena Martinez, Vitali Sintchenko, Peter J. Rutledge & James A. Triccas. (2019) Bengamides display potent activity against drug-resistant Mycobacterium tuberculosis. Scientific Reports 9:1.
Crossref
Farah Ballout, Zeina Habli, Alissar Monzer, Omar Nasser Rahal, Maamoun Fatfat & Hala Gali-Muhtasib. 2019. Bioactive Natural Products for the Management of Cancer: from Bench to Bedside. Bioactive Natural Products for the Management of Cancer: from Bench to Bedside 1 35 .
G. Deepa, K. C. Sivakumar & T. P. Sajeevan. (2018) Molecular simulation and in vitro evaluation of chitosan nanoparticles as drug delivery systems for the controlled release of anticancer drug cytarabine against solid tumours. 3 Biotech 8:12.
Crossref
Lucy Swift, Aarthi Jayanthan, Yibing Ruan, Ronald Anderson, Jessica Boklan, Tanya Trippett & Aru Narendran. (2018) Targeting the Proteasome in Refractory Pediatric Leukemia Cells: Characterization of Effective Cytotoxicity of Carfilzomib. Targeted Oncology 13:6, pages 779-793.
Crossref
Yanyan Chu, Zhenhua Tian, Yingwei Hou & Wenbao Li. (2018) Study on the Preparation and Antileukemic Activity of New Lipophilic 1-β-D-arabinofuranosylcytosine Derivatives. Journal of Ocean University of China 17:2, pages 385-391.
Crossref
Ruiling Liu, Jing Zhang, Di Zhang, Kaiming Wang & Yuxia Luan. (2018) Self-assembling nanoparticles based on cytarabine prodrug for enhanced leukemia treatment. Journal of Molecular Liquids 251, pages 178-184.
Crossref
Ricardo Calado, Miguel Costa Leal, Helena Gaspar, Susana Santos, António Marques, Maria Leonor Nunes & Helena Vieira. 2018. Grand Challenges in Marine Biotechnology. Grand Challenges in Marine Biotechnology 317 403 .
Feng Liu, Xiaohu Qin, Dinghua Xiao, Xu Dai, Xing Peng & Tieyu Chen. (2017) Towards site-specific nanoparticles for drug delivery application: preparation, characterization and release performance. Chemical Papers 71:12, pages 2385-2394.
Crossref
Renato B. Pereira, Ramesh Dasari, Florence Lefranc, Alexander Kornienko, Robert Kiss & Nelson G. M. Gomes. 2017. Natural Products Targeting Clinically Relevant Enzymes. Natural Products Targeting Clinically Relevant Enzymes 255 275 .
Jinsuo Yang, Gang Qian, Yanyang Wu, Xiangyang Zhang, Yang Liu, Zhenwu Li & Xinggui Zhou. (2017) Thermodynamic analysis of the solubility of polymorphic cytarabine in a variety of pure solvents. Fluid Phase Equilibria 445, pages 1-6.
Crossref
Anfal Jasim, Sara Abdelghany & Khaled Greish. 2017. Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes. Nanotechnology-Based Approaches for Targeting and Delivery of Drugs and Genes 62 109 .
W. Gallimore. 2017. Pharmacognosy. Pharmacognosy 377 400 .
Danuta Pentak, Violetta Kozik, Andrzej Bąk, Paulina Dybał, Aleksander Sochanik & Josef Jampilek. (2016) Methotrexate and Cytarabine—Loaded Nanocarriers for Multidrug Cancer Therapy. Spectroscopic Study. Molecules 21:12, pages 1689.
Crossref
Dong Zhang, Dongpo Li, Lei Shang, Zhonggui He & Jin Sun. (2016) Transporter-targeted cholic acid-cytarabine conjugates for improved oral absorption. International Journal of Pharmaceutics 511:1, pages 161-169.
Crossref
Aleksandra Szulc, Marco Signorelli, Alberto Schiraldi, Dietmar Appelhans, Brigitte Voit, Maria Bryszewska, Barbara Klajnert-Maculewicz & Dimitrios Fessas. (2015) Maltose modified poly(propylene imine) dendrimers as potential carriers of nucleoside analog 5′-triphosphates.. International Journal of Pharmaceutics 495:2, pages 940-947.
Crossref
Luis E. Iglesias, Elizabeth S. Lewkowicz, Rosario Medici, Paola Bianchi & Adolfo M. Iribarren. (2015) Biocatalytic approaches applied to the synthesis of nucleoside prodrugs. Biotechnology Advances 33:5, pages 412-434.
Crossref
Sophie Marchal, Amélie El Hor, Marie Millard, Véronique Gillon & Lina Bezdetnaya. (2015) Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics. Drugs 75:14, pages 1601-1611.
Crossref
V. P. Krasnov, A. Yu. Vigorov, D. A. Gruzdev, G. L. Levit, A. M. Demin, I. A. Nizova, A. A. Tumashov, L. Sh. Sadretdinova, E. B. Gorbunov & V. N. Charushin. (2016) Synthesis of enantiomers of N-(2-aminopurin-6-yl)amino acids. Russian Chemical Bulletin 64:9, pages 2106-2113.
Crossref
Haiyan Guo, Shuai Sun, Zhenhua Yang, Xing Tang & Yanjiao Wang. (2015) Strategies for ribavirin prodrugs and delivery systems for reducing the side-effect hemolysis and enhancing their therapeutic effect. Journal of Controlled Release 209, pages 27-36.
Crossref
Bhupender S. ChhikaraM. Sudershan RaoV. Kameshwara RaoAnil KumarKaren W. BuckheitRobert W. Buckheit Jr.Keykavous Parang. (2014) Carbocyclodipeptides as modified nucleosides: synthesis and anti-HIV activities. Canadian Journal of Chemistry 92:12, pages 1145-1149.
Crossref
Ugo Pradere, Ethel C. Garnier-Amblard, Steven J. Coats, Franck Amblard & Raymond F. Schinazi. (2014) Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs. Chemical Reviews 114:18, pages 9154-9218.
Crossref
Hayley Nehoff, Neha N. Parayath, Sebastien Taurin & Khaled Greish. 2014. Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology. Handbook of Nanotoxicology, Nanomedicine and Stem Cell Use in Toxicology 65 86 .
Chun-hui Liang, Wei-liang Ye, Chun-lai Zhu, Ren Na, Ying Cheng, Han Cui, Dao-zhou Liu, Zhi-fu Yang & Si-yuan Zhou. (2014) Synthesis of Doxorubicin α-Linolenic Acid Conjugate and Evaluation of Its Antitumor Activity. Molecular Pharmaceutics 11:5, pages 1378-1390.
Crossref
Ana Martins, Helena Vieira, Helena Gaspar & Susana Santos. (2014) Marketed Marine Natural Products in the Pharmaceutical and Cosmeceutical Industries: Tips for Success. Marine Drugs 12:2, pages 1066-1101.
Crossref
Alexey Yu. Vigorov, Viktor P. Krasnov, Dmitry A. Gruzdev, Alisa A. Men'shikova, Alexander M. Demin, Galina L. Levit & Valery N. Charushin. (2014) Novel synthetic routes to N-(2-amino-9H-purin-6-yl)-substituted amino acids. Mendeleev Communications 24:1, pages 35-36.
Crossref
Shayne Cox GadHayley Nehoff, Sebastien Taurin & Khaled Greish. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Jianxun Ding, Fenghua Shi, Di Li, Li Chen, Xiuli Zhuang & Xuesi Chen. (2013) Enhanced endocytosis of acid-sensitive doxorubicin derivatives with intelligent nanogel for improved security and efficacy. Biomaterials Science 1:6, pages 633-646.
Crossref
K. Franke, M. Baur, L. Daum, M. Vaegler, K.-D. Sievert & B. Schlosshauer. (2013) Prostate carcinoma cell growth-inhibiting hydrogel supports axonal regeneration in vitro. Neuroscience Letters 541, pages 248-252.
Crossref
Amir Nasrolahi Shirazi, Rakesh Tiwari, Bhupender S. Chhikara, Dindyal Mandal & Keykavous Parang. (2013) Design and Biological Evaluation of Cell-Penetrating Peptide–Doxorubicin Conjugates as Prodrugs. Molecular Pharmaceutics 10:2, pages 488-499.
Crossref
Mai Thanh Quynh Tran, Evelyne Furger & Roger Alberto. (2013) Two-step activation prodrugs: transplatin mediated binding of chemotherapeutic agents to vitamin B12. Organic & Biomolecular Chemistry 11:19, pages 3247.
Crossref
Sebastien Taurin & Khaled Greish. 2013. Tight Junctions in Cancer Metastasis. Tight Junctions in Cancer Metastasis 81 118 .
Sebastien Taurin, Hayley Nehoff, Thalita van Aswegen & Khaled Greish. 2013. Cancer Targeted Drug Delivery. Cancer Targeted Drug Delivery 207 239 .
Sebastien Taurin, Hayley Nehoff & Khaled Greish. (2012) Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?. Journal of Controlled Release 164:3, pages 265-275.
Crossref
Sarah Schott, Heike Niessner, Tobias Sinnberg, Sascha Venturelli, Alexander Berger, Kristian Ikenberg, Jessie Villanueva, Friedegund Meier, Claus Garbe & Christian Busch. (2012) Cytotoxicity of new duplex drugs linking 3′‐C‐ethynylcytidine and 5‐fluor‐2′‐deoxyuridine against human melanoma cells. International Journal of Cancer 131:9, pages 2165-2174.
Crossref
Mousa Jafari, Bahram Zargar, M. Soltani, D. Nedra Karunaratne, Brian Ingalls & P. Chen. 2012. Biomedical Materials and Diagnostic Devices. Biomedical Materials and Diagnostic Devices 477 513 .
Bhupender S. Chhikara, Rakesh Tiwari & Keykavous Parang. (2012) N-Myristoylglutamic acid derivative of 3′-fluoro-3′-deoxythymidine as an organogel. Tetrahedron Letters 53:39, pages 5335-5337.
Crossref
Bhupender S. Chhikara, Deendayal Mandal & Keykavous Parang. (2012) Synthesis, Anticancer Activities, and Cellular Uptake Studies of Lipophilic Derivatives of Doxorubicin Succinate. Journal of Medicinal Chemistry 55:4, pages 1500-1510.
Crossref
V. Kameshwara Rao, Bhupender S. Chhikara, Rakesh Tiwari, Amir Nasrolahi Shirazi, Keykavous Parang & Anil Kumar. (2012) One-pot regioselective synthesis of tetrahydroindazolones and evaluation of their antiproliferative and Src kinase inhibitory activities. Bioorganic & Medicinal Chemistry Letters 22:1, pages 410-414.
Crossref
Alicia Fernandez-Fernandez, Romila Manchanda & Anthony J. McGoron. (2011) Theranostic Applications of Nanomaterials in Cancer: Drug Delivery, Image-Guided Therapy, and Multifunctional Platforms. Applied Biochemistry and Biotechnology 165:7-8, pages 1628-1651.
Crossref
Adrian S. Ray & Karl Y. Hostetler. (2011) Application of kinase bypass strategies to nucleoside antivirals. Antiviral Research 92:2, pages 277-291.
Crossref
Herbert Schott, Daniel Goltz, Timm C. Schott, Claudia Jauch & Reto A. Schwendener. (2011) N4-[Alkyl-(hydroxyphosphono)phosphonate]-cytidine—New drugs covalently linking antimetabolites (5-FdU, araU or AZT) with bone-targeting bisphosphonates (alendronate or pamidronate). Bioorganic & Medicinal Chemistry 19:11, pages 3520-3526.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.